The Long-Acting Opioid Market Was Valued At Over $3 Billion in 2007, and Is Due To Grow Until the Patent Expiry of Market Leader Oxycontin In 2011 (Business Wire)
DUBLIN, Ireland—-Research and Markets has announced the addition of Commercial and Pipeline Insight: Opioids - Short acting and anti-abuse technologies set to fragment and grow the market to their offering.